Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQWG0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,573
Award facts
- Contract value 100% obligated
- $25,573.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a $25,573.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The contract, which carries no set-aside designation, is scheduled for completion by January 6, 2026, and represents a discrete procurement under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the agency. As the sole awardee, DMS Pharmaceutical Group will fulfill this pharmaceutical supply requirement for Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, a $30.3 billion government-wide acquisition strategy administered by the Defense Logistics Agency. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the agency to issue firm fixed-price orders for comprehensive pharmaceutical products and medical consumables to support global military healthcare operations. DMS Pharmaceutical Group's established performance across numerous delivery orders and its designation as one of multiple regional prime vendor contractors under this initiative position the company as a critical supplier within the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQWG0?
SPE2DR26FQWG0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FQWG0 worth?
The government has obligated $25,573 on SPE2DR26FQWG0.
Is contract SPE2DR26FQWG0 an order under another contract?
Yes. SPE2DR26FQWG0 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWG0 competed?
The extent of competition for SPE2DR26FQWG0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award